SCHEMBL7919565

SCHEMBL7919565

O=C(N[C@@H]1CCc2ccccc21)C1(Cc2ccccc2)CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.50
SMYD3 Q9H7B4 1/20 0.45
P2RX7 Q99572 1/20 0.44
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 2/20 0.43
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HTT P42858 1/20 0.43
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP8 P22894 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
EPHX1 P07099 1/20 0.41
SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7921872 1.00 EPHX2 (0.50) EPHX2SMYD3P2RX7ROCK2ROCK1
SCHEMBL7919569 0.82 MTNR1A (0.49) SMYD3SLC6A2SLC6A4SLC6A3
SCHEMBL13092157 0.80 HTT (0.48) EPHX2P2RX7TAS1R3TAS1R1TAS1R2
SCHEMBL7922905 0.80 MME (0.48) SMYD3KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL7910472 0.79 SSTR4 (0.41) SMYD3MMP9SLC6A2SLC6A4SLC6A3
SCHEMBL7919878 0.78 EPHX1 (0.50) EPHX2SMYD3SMN1; SMN2ALDH1A1MEN1
SCHEMBL3421690 0.76 EPHX2 (0.42) EPHX2P2RX7ROCK2ROCK1TAS1R3
SCHEMBL2461656 0.73 ALDH1A1 (0.63) EPHX2ROCK2ROCK1TAS1R3TAS1R1
SCHEMBL4375995 0.73 SLC6A2 (0.50) SMYD3MMP1MEN1KMT2ASLC6A2
Hydrochloric Acid SCHEMBL5969836 0.72 ALDH1A1 (0.62) EPHX2ROCK2ROCK1TAS1R3TAS1R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010054968-A1 QUINAZOLINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-05-20 WO disclosed